Given the current torrid pace of sales for some categories, the dietary supplement industry could emerge from the present crisis is a significantly strengthened position. Even categories that are in the doldrums stand to benefit.
Marketers of natural products need to be on their best behavior during this pandemic crisis as regulatory authorities comb through every aspect of a company’s marketing to look for disease claims, an attorney says.
Mile High Labs has submitted a European novel foods dossier for its CBD isolate. According to Christian Hendriksen, vice president of international expansion, compliance with novel food regulations will help move CBD into the FMCG mainstream.
Health Canada has reiterated its stance that changes to product labels due to reclassification of species within the old Lactobacillus genus should occur within three years of changes to its monograph.
The sad news came this week of the death of a young girl who started a movement, one which has exposed again the built-in strains of how the dietary supplement market is regulated in the United States.
Neptune Health and Wellness has received approval to transition one of its facilities for the production of hand sanitizer, the company announced today.
The US Food and Drug Administration has issued an additional six warning letters in recent days on coronavirus claims. The letters coincide with an industry coalition raising a red flag on the growing flood of such claims on dietary supplement-type products.
A coalition of dietary supplement industry trade associations have come out in support of FDA actions against fraudulent coronavirus treatment claims and have urged retailers to not stock products with such claims on their labels.
An omega-3 origin verification tech company is working to boost awareness in an aim to build a new and improved level of trust and transparency across the industry.
The dietary supplement industry has an opportunity to communicate with a new range of consumers in light of the current crisis. Highlighting the excellent safety of the products and quality initiatives underway can help keep the embarrassment of rampant...
The Botanical Adulteration Prevention Program has issued a lab guidance document on turmeric. The publication is timely as interest in the botanical, which was already high, has spiked during the current coronavirus crisis.
A ruling on an Amarin patent and a new paper looking through data of a clinical trial on the company’s EPA-based drug have potential implications for the omega-3s dietary supplements sector.
The US Food and Drug Administration has issued another warning letter on COVID-19 claims. This one was issued to a Nevada company marketing CBD products.
The increasing popularity of cannabidiol (CBD) only underscores the need for accurate and informative labeling of hemp and hemp-derived CBD products, according to researchers.
